Quantcast
Skip to main content
Department of Pathology and Laboratory Medicine

Department of Pathology and Laboratory Medicine

Shiloh Martin, M.D., Ph.D.

Resident, PGY 1
4400 V Street,
Sacramento, CA 95817

Medical School

UC Davis School of Medicine, Sacramento CA

Personal Interests

New parenthood, traveling, skiing, going to the movies, and baking

Reason for selecting UC Davis for Residency

Attendings, residents and staff are knowledgeable, friendly and work to promote a collaborative atmosphere

Clinical Interests

  • General pathology
  • Hematopathology

Research Interests

  • General pathology
  • Hematopathology

CV Highlights

  • B.S. from Loyola University, Chicago, IL, double major in biology and English
  • Ph.D. from UC Davis, Immunology

Publications, Abstracts or Posters

Martin SM, Churchill E, McKnight H, Mahaffey CM, Ma Y, O'Donnell RT, Tuscano JM.  The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner.  J Hematol Oncol. 2011 Dec 1;4:49.  PMID: 22128838

Tuscano JM, Ma Y, Martin SM, Kato J, O'Donnell RT.  The Bs20x22 anti-CD20-CD22 bispecific antibody has more lymphomacidal activity than do the parent antibodies alone.  Cancer Immunol Immunother. 2011 Jun; 60(6): 771-80.  Epub 2011 Feb 24.  PMID: 21347809

Tuscano JM, Martin SM, Ma Y, Zamboni W, O'Donnell RT.  Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.  Clin Cancer Res. 2010 May 15;16(10):2760-8. Epub 2010 May 11.  PMID: 20460479 

 

 

 

Link to PubMed